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Abstract. Meta-analysis can be valuable if it heeds its originators’ caution that intimate communing
with the data is essential. A critique of the authors’ own meta-analysis shows that the danger of
overly broad conclusions could be reduced by attention to specificities and awareness of potentially
hidden sources of variance. Conclusions from even good meta-analyses are best placed in
perspective, along with naturalistic reviews, open studies, and even anecdotes to yield a fair picture of
what computer-aided psychotherapy or any other treatment can achieve under varying conditions.
The most realistic picture comes from zooming in and out and melding meta-analyses with further
types of evidence. Key words: meta-analysis critique; computer-aided psychotherapy; self-help.
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The plethora of randomised controlled trials
(RCTs) in health care has stimulated research-
ers to devise ways of summarising outcomes
across RCTs of particular treatments for
particular problems by performing meta-
analyses (MAs). MAs use quantitative meth-
ods to combine results from different studies
to give a single estimate of effect and to help
clinicians, researchers, and health care funders
see the wood for the trees.
Methods to design, run, and analyse RCTs
and perform MAs for outcome analysis across
RCTs have improved iteratively since their
start decades ago (Smith & Glass, 1977). MAs,
a form of systematic review, have been of
undoubted benefit in speeding the sifting of
masses of health care evidence. MAs have been
boosted by Cochrane reviews (Cochrane
Collaboration, 2008), which claim to be reli-
able, independent, and comprehensive—the
‘‘gold standard’’ of evidence-based health care
to influence decision-making by health carers,
researchers, and policy-makers.
Busy people rely on the kitemarks of MAs
and of Cochrane reviews to see trends at a
glance. It is thus timely to audit such audits.
How comprehensive and accurate are MAs?
How carefully can their conclusions reflect the
complexities of comparisons across RCTs,
which may differ widely in the questions they
ask and answers given based on diverse
designs, measures and types of analyses, and
how generalisable can the conclusions of MAs
across such varied studies be to everyday
practice in health care? Some pitfalls in MAs
were noted at their start by Smith and Glass
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(1977) and more recently by Rosenthal and
DiMatteo (2001) and Sensky (2005).
Important differences can all too easily be
obscured by computer-programmed calcula-
tions to several decimal points of standardized
mean effect size (ES), random- and fixed-
effects models, Q and I2 statistics of hetero-
geneity, tests of publication bias, relative
risks, odds ratios, confidence intervals, con-
cealment of randomisation, dropouts at each
stage, and testing of rater blindness. Such
statistics are needed but might still ignore vital
details hidden in a short phrase in a paper or
unreported but emergent only on chatting
with researchers, who may have regarded such
issues as being too trivial to report, an opinion
presumably shared with the referees and
editors of the journals, even high-impact ones,
who published the results. Such details can
obscure problems in interpreting MA evalua-
tions of health care. This comment is no
criticism of authors, referees, or editors.
Potentially important but unreported issues
may emerge only with the wisdom of hind-
sight long after publication, a point applying
as much to our own studies as to those of
other researchers.
The present report critiques our own MA
of computer-aided psychotherapy (CP) for
anxiety disorders in this issue (Cuijpers et
al., 2009) to illustrate problems that are
common in MAs and need hard work to
solve even partially. The devil is in the
detail. We ask how MAs might be made
more transparent regarding how they choose
the RCTs they include, the subgroups they
analyse, and how far their findings can be
generalised when upscaling implementation
in widely differing health care systems. We
find that conclusions can only be very
tentative from even the most transparent
and sophisticated MAs that are possible.
Combining the results of MA with insights
from narrative reviews (e.g. Marks,
Cavanagh, & Gega, 2007) may allow a more
balanced appreciation of the role of CP in
health care, although this will not completely
solve the problems described here. Our MA
asked what the effects are in (1) anxiety
disorders of (2) CP compared with (3) a
contrasting (control, inactive) non-CP con-
dition. The question seems simple enough,
but the answer is not as a result of
diversities that can trap the unwary.
Diversity across anxiety disorders
The term anxiety disorder is a movable feast
that is not always easy to pin down. The
International Classification of Diseases (10th
edition [ICD-10]) and Diagnostic and
Statistical Manual of Mental Disorders (fourth
edition; DSM-IV]) categories can be incon-
gruent (e.g. obsessive–compulsive disorder
[OCD] is not an anxiety disorder in ICD-10
but is in DSM-IV, while agoraphobic avoid-
ance is excluded from the panic disorder
category more in ICD-10 than in DSM-IV.
Agoraphobic avoidance with or without panic
leads to more disability than does panic per se,
so ICD-10 and DSM-IV panic disorder
samples may differ in degree of disability,
whereas DSM-IV pure panic disorder samples
without agoraphobia are less disabled than
DSM-IV patients who have both panic and
agoraphobic avoidance. The most common
anxiety problems in primary care are probably
generalised anxiety disorder and mixed anxi-
ety/depression and are loose-knit diagnoses.
Different anxiety disorder samples vary in,
among others, chronicity, degree of disability,
and course and in response to treatment,
which itself may partly depend on the fore-
going. MAs can try to handle this issue by
including only RCTs of CP that concern just
one ICD or DSM category, but at present
this cuts the number of RCTs qualifying
for inclusion drastically, thereby limiting
conclusions.
Even if the MA concerns RCTs of patients
with a clearly defined anxiety disorder,
another source of variance is how the
patients were sought and screened and what
proportions were self- or general practitioner
(GP) referrals or already on a wait list for
face-to-face psychotherapy from mental
health care professionals. The more filters
they pass through to get into an RCT, the
more likely they are to be more chronic and
severe and perhaps more difficult to help.
They might also be less motivated if they have
been discouraged from doing CP by a
referring mental health professional who
worries about losing customers. Compared
with referrals from mental health profes-
sionals, GP and self-referrals complied
more with CP instructions and improved
more (Mataix-Cols, Cameron, Gega,
Kenwright, & Marks, 2006). As with single
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diagnoses, MAs will currently find too few
RCTs of CP with enough data about sources
of referral to allow reliable subgroup analysis
of this issue.
Diversity across CP
Different modes of delivering CP
Working out a mean ES of CP is about as
useful as working out a mean ES of pharma-
cotherapy, covering a huge range of com-
pounds and ways of getting them onto or into
the body. Just as a vast number of medica-
tions might be delivered as an ointment,
powder, or drops on the skin, eyes, or ears,
inhaled as a spray, put under the tongue,
swallowed as a tablet, capsule, powder, or
wafer, injected subcutaneously, intramuscu-
larly, or intravenously, or inserted as an anal
or vaginal pessary, so CP systems can be
delivered on a range of devices such as stand-
alone or Internet-linked computers, PCs,
palmtops, phone-interactive voice response,
CD-ROMS, DVDs, cell phones, and virtual
reality devices (Marks et al., 2007). Each of
these modes of delivery has its own pros and
cons. Lumping all RCTs into a single MA
risks missing potentially crucial differences in
effectiveness, with too few RCTs in given
subgroups for meaningful analyses.
Differing contents and styles of CP
systems
Mode of delivery aside, CP systems for
anxiety disorders vary widely in their content
and style. They may facilitate homework
between face-to-face CBT sessions, give
respiratory feedback, or aid vicarious in-
session exposure in a clinic or direct self-
exposure outside the clinic, writing exposure,
or cognitive restructuring. In style, they may
be page-turners (bibliotherapy on a screen),
with tests like a college course suitable for
educated users, may just show pictures on a
screen, or may be more interactive simulations
of a series of clinical sessions. RCTs rarely
report duration and pacing of system use.
These variables are hard to control, especially
with CP used on the Internet at home or
elsewhere outside a clinic. Users of given CP
systems differ in the speed with which they can
digest and implement CP guidance. Some may
use a system for long sessions but infrequently
over a long period, whereas others may use it
often in brief sessions that can add up to a
shorter total time and period of use. Such
variables may affect the support that users get
from a human if that is given regularly (e.g.
once a week over the total period of system
use) rather than when the user gets to a
particular point in the system.
Differing durations and types of human
contact during CP
CP, unlike the withdrawal of cash from an
automatic-teller machine, is rarely completed
with no human contact at all by e-mail, phone,
or face-to-face at any stage from first screen to
end of follow-up. CP is thus generally ‘‘CP plus
some human contact, which varies vastly in
duration and type’’ across RCTs. To be
meaningful, an MA has to dissect these care-
fully, but this is easier said than done. Let us
take examples from Marks et al. (2007). An
RCT report of Interapy (Lange et al., 2003) did
not mention therapist time, but, in fact,
Interapy requires a mean of 14 hr of therapist
support by e-mail (Ruwaard and Lange,
personal communication, June 30, 2008 and
July 9, 2008), whereas in the RCTs of Hassan
(1992) and Bornas, Tortella-Feliu, Llabres,
and Fullana (2001), a therapist sat with the
patient throughout CP sessions. In these
RCTs, a therapist spent as much time with
CP patients as is usual during face-to-face
exposure therapy in the United Kingdom, so
by that the UK criterion the CP saved no
therapist time or cost, a vital issue for cost-
effectiveness. Palmtop and virtual reality sys-
tems had much therapist contact. Our MA of
CP (Cuijpers et al., 2009, this issue) found the
highest ESs of all in the Hassan (1992) and the
Bornas et al. (2001) RCTs and a high ES in the
Lange RCT; in those studies, however, CP was
an add-on to a usual duration of therapist
contact in the United Kingdom, even if that
contact was just either sitting passively with the
patient during CP or reading patients’ e-mails
and replying by e-mail.
At the other extreme of duration is zero
therapist time with CP users, as in a multi-
centre RCT of patients using BTSteps at
home (Greist et al., 2002). However, in that
RCT, the multicentre ethical committees
insisted on patients in each arm attending a
clinic four times in the course of the RCT to
see a clinician for brief safety checks, not
therapy. Such clinic contact did not improve
VOL 38, NO 2, 2009 Meta-analysis of CP: Problems and partial solutions 85
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non-CP patients, but perhaps it enhanced
compliance with CP beyond that seen with CP
under everyday conditions. MAs of RCTs
asking patients to attend a clinic for whatever
reason or to make repeated outcome ratings
are unlikely to yield reliable conclusions about
the outcome of CP used at home or in a
library under field conditions. Casual unmo-
nitored registrants at CP websites have far
higher dropout rates than participants in the
demanding conditions of RCTs of CP on the
Internet (Eysenbach, 2005), one example
being community users of the MoodGym
program (Christensen, Griffiths, Groves, &
Korten, 2006), with huge attrition rates.
In a meta-regression analysis, our MA
found that ES rose with longer therapist
contact. It could not determine whether this
rise was directly proportional to longer dura-
tion of CP use, nor could it test dose–response
issues adequately (e.g. whether just 5 min of
instructive, encouraging contact once only or
a few times might yield a higher ES than much
longer contact) or whether effects differed
according to content of the contact or level of
expertise of the contact provider (i.e. a highly-
trained professional or a very briefly-trained
lay person). Nor could our MA test the
interaction of such variables with different
CP systems and different anxiety disorders.
Our MA revealed an RCT that found better
outcome with CP if users had scheduled rather
than unscheduled phone support by a profes-
sional (Kenwright, Marks, Graham, Franses,
& Mataix-Cols, 2005), but excluded it from
analysis because both its arms involved CP
(see below). Nor could our MA find enough
RCTs for subgroups to judge whether contact
was better face-to-face or by phone, e-mail,
SMS text message, or a combination of these.
This means an MA definition of heterogeneity
in terms of ES alone is too simple, because
studies yielding similar ESs were nevertheless
heterogeneous in important other respects
(e.g. reduction in therapist time varying from
0% to 100% or varying educational level of
participants across studies). Such heterogene-
ities limit the comparability of, and conclu-
sions that can safely be drawn from, MAs of
RCTs.
RCTs are said to be a gold standard of
evidence. Appropriately designed RCTs can
indeed give good answers to carefully for-
mulated questions under tightly regulated
conditions. However, RCTs have limited
ability to judge performance under less
tightly-regulated conditions in routine care.
This problem is inevitable with MAs, too,
because they only analyse RCTs, not field
studies of dissemination. Some dissemination
issues might be tested by doing cluster RCTs,
in which the units of randomisation to CP
versus non-CP are separate geographical
areas/institutions/other entities rather than
individual patients. Unfortunately, such
RCTs are very rare and need even more work
and funding than RCTs that randomise
individuals, so MAs cannot find enough to
include. Moreover, in a cluster RCT, the non-
CP arm would require as much attention-
placebo and regulation as the CP arm, so the
non-CP arm would no longer represent
routine conditions for dissemination, even if
patients are recruited in routine care and the
therapists work in routine care. This uncer-
tainty principle applying to RCTs applies to
MAs of RCTs as well.
Diversity across control non-CP
contrast conditions
RCTs are the raw material for MAs. A
common belief is that RCTs can have an
ideal control (contrast) group. In fact, any
control group can only advance knowledge to
the extent that it can answer the particular
questions posed by the RCT. It is vital to
scrutinise the potentially therapeutic ingredi-
ents in each group compared. For example,
many RCTs compared CP plus human sup-
port with a wait-list (delayed-treatment) or
treatment-as-usual (TAU) condition and
judged CP to be superior. That superiority
might reflect the greater activity and attention
accompanying CP rather than the CP per se,
in which case the CP would be redundant, like
any other treatment that was no better than a
comparable attention-placebo condition.
Such attention-placebo confounds cannot
be compensated by the large sample sizes,
masked randomisation, blind ratings, low
dropout rates, and rigorous statistics that get
good grades in systematic reviews. Different
expectancies across groups could be reduced
by wait-list or TAU patients being told that
they may improve just with the passage of
time, although they are rarely told this.
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Wait-list and TAU contrast groups try to
answer the question, ‘‘Does introducing CP
improve the existing situation?’’ but cannot
distinguish CP’s effect from its accompanying
attention-placebo effect unless the wait-list
and TAU groups, too, have an added atten-
tion-placebo component; but then the RCT is
no longer testing an ordinary wait-list or TAU
condition. A regulatory body would not
approve any drug or psychological treatment
from results based on an RCT comparing it
with a wait-list or TAU condition without an
attention-placebo giving a comparable expec-
tation of improvement. The same logic applies
to CP trials. This questions our MA’s inclu-
sion of ESs from RCTs using wait-list or TAU
contrast conditions. An active attention-pla-
cebo for phobias and obsessive–compulsive
disorder (OCD) could, for example, be
relaxation sessions without exposure + relaxa-
tion homework without exposure + relaxation
diaries without exposure. Patients find such
relaxation acceptable and tend to drop out
less from it than from CP proper, even though
relaxation without exposure is known to be
ineffective for phobias and OCD, unlike
applied relaxation, which does contain expo-
sure (O¨st, 1987). A second acceptable atten-
tion-placebo for anxiety disorders could be
free-association sessions with matching home-
work and diaries excluding exposure. A third
is antiexposure (Marks, 1987). Our MA’s
subgroup analysis found no effect on ES of
type of control (wait-list vs. relaxation), but
there were only two studies of relaxation
without exposure, and ‘‘other’’ may be too
broad a category to be meaningful, so this
question remains unresolved.
Another non-CP issue concerns the defini-
tion of ‘‘wait list.’’ Our MA excluded the
study by Klein, Richards, and Austin (2006),
because its wait-list group not only had access
to an information website but also weekly
contact in which they were asked whether they
did their registration exercises. This further
shows the difficulties in deciding which studies
to include. ‘‘Wait list’’ can describe somewhat
differing conditions across different authors,
and it is not known how these may affect
outcome.
MAs can be bedeviled by surprising results
because of current lack of knowledge about
which nonexposure psychotherapy procedures
are good attention-placebo controls (contrasts)
that reliably do not improve anxiety disorders.
A case in point is our MA’s legitimate exclusion
of an RCT of CP guiding self-exposure for
phobia/panic (Schneider, Mataix-Cols, Marks,
& Bachofen, 2005) because its description of the
control condition appeared, in fact, to contain
active elements. However, its intended control
attention-placebo condition, ‘‘managing anxi-
ety,’’ included relaxation, problem-solving,
physical, and breathing exercises and distrac-
tion but excluded both exposure and systematic
cognitive restructuring. Some serious cognitive
behaviour therapists would not call this con-
trast condition CBT, yet it turned out to work
unexpectedly well by posttreatment, although
less so at follow-up. Our MA thus includes an
RCT (Marks, Kenwright, McDonough,
Whittaker, & Mataix-Cols, 2004) comparing
CP with a computer-aided relaxation-placebo,
which was ineffective at both posttreatment and
follow-up, but excludes another RCT
(Schneider et al., 2005) comparing similar CP
with a different computer-aided condition that
was intended to be an inactive attention-placebo
throughout but turned out to be less effective
than CP only at follow-up. Was the Schneider et
al. (2005) RCT controlled for non-CP based on
results at follow-up but not for non-CP based
on results at posttreatment? A treatment arm
intended to be an inactive attention placebo
turned out to be surprisingly active in the short
term. Related uncertainties about exclusion
criteria arise with other studies (Fraser,
Kirkby, Daniels, Gilroy, & Montgomery,
2001; Newman, Consoli, & Taylor, 1997).
There is no clear answer. MAs, including our
own, are inevitably arbitrary in some ways even
when the meta-analyst tries to specify clear-cut
criteria for including and excluding studies.
Clearly, complex conundrums confounded
our choice of non-CP studies for inclusion in
MAs. The choice can be moot however hard
we strive for objectivity. The criterion for
inclusion of CP versus a non-CP control can
be too fuzzy to decide. Any study that
contrasts an experimental treatment with a
contrasting condition is, in a sense, controlled.
For example, the Schneider et al. (2005) RCT
controlled for presence of active exposure and
cognitive restructuring instructions during
computer guidance and so had a non-CP
control. The Kenwright et al. (2005) RCT
controlled for type of human contact during
CP but had no non-CP control.
VOL 38, NO 2, 2009 Meta-analysis of CP: Problems and partial solutions 87
D
o
w
n
lo
ad
ed
 B
y:
 [
Vr
ij
e 
Un
iv
er
si
te
it
, 
Li
br
ar
y]
 A
t:
 1
2:
20
 2
6 
No
ve
mb
er
 2
01
0
Diversity of outcome across measures
ESs can vary considerably across different
measures within a given RCT, and simply
pooling them is not always a satisfactory
solution. For example, in a non-CP RCT of
panic/agoraphobia (Marks et al., 1993), panic
improved hugely with placebo but phobic
avoidance and work/social adjustment did
not. Target-phobia measures improve more
with CBT, and earlier, than global-phobia
measures, which, in turn, improve earlier than
work/social adjustment measures. In such
cases, one has to qualify outcomes in MAs
regarding which measures improved and
when.
Limitations of MAs
MAs lose much by excluding non-RCT
evidence, although meta-analyses of open
pre–post studies are possible but are not
usually held in high regard. No kind of
evaluation is ideal for all purposes. Sticking
solely to a supposed gold standard of RCTs
may neglect potentially crucial issues raised by
anecdotes, case studies, and open trials. A few
anecdotes make the point. First, in an early
three-arm RCT of CP (Ghosh, Marks, &
Carr, 1988) that compared self-exposure
guidance given by CP, by a self-help book,
or by face-to-face therapy, two patients who
had been randomised to the book arm turned
out to have bought that book in a shop but
never opened it until they entered the trial and
were asked by a psychiatrist to read the book
and follow its guidance, which they did and
then improved. The RCT’s self-help book arm
turned out to be testing not the value per se of
a self-help book bought casually in a shop,
but of that book recommended strongly by a
health caregiver in a trial where the patients
were asked to return to a clinic at intervals for
assessment. How does one do an RCT to test
the value of casually buying the book either
with or without a professional recommenda-
tion? No RCTs means no MAs. Guidance on
this kind of issue may have to rest on
anecdotal evidence or perhaps epidemiologi-
cal studies on the uptake and outcome of self-
help materials in the general public.
Two more stories concern CP’s confidenti-
ality. During recruitment for CP trials, many
patients said they valued CP’s confidentiality
and would not enter the trial if their GP had
to be informed of the fact, and one said he
would not dare enter the door of a CP clinic
lest others outside saw him going there.
Second, when a nurse asked if he could watch
a patient doing CP at a computer screen in a
clinic, the patient said, ‘‘Sure, just stand
behind me.’’ As certain information unfolded
on the screen, the nurse exclaimed, ‘‘You
didn’t tell us that!,’’ whereupon the patient
turned and said, ‘‘Of course not; it’s con-
fidential.’’ ‘‘Confidential’’ here implied that
the patient would not reveal that information
face-to-face but did not mind staff learning
about it less directly, a subtlety rarely
recognised in discussions of ‘‘confidential’’
although implied when patients in psycho-
analytic sessions lie on a couch facing away
from the analyst or when Catholics are
screened from their priest during confession.
Again, RCTs, and hence MAs, to tease out
such issues are hard to devise.
RCTs and hence MAs are also hard put to
address vital aspects of health care apart from
efficacy (e.g. patient choice and preference). It is
difficult enough for professionals to examine the
value and convenience of different types of CP
and their delivery. The snags are greater still for
the average person on the street beset even more
by many marketing variables, including the
reservations of professionals who might mis-
takenly fear being supplanted by computers and
of funders of health care. When RCT evidence
convinced the UK National Institute for Health
and Clinical Excellence (2006) to recommend
that every primary care trust in England and
Wales should use one CP system to manage
depression and another to manage phobia/
panic, many barriers to optimum implementa-
tion were encountered, including professionals’
resistance, funding pressures, organisational
rigidities, and contending self-help approaches.
There is no free lunch in health care. MAs
can be a major step forward if they heed the
original caution of Smith and Glass (1977):
‘‘Intimate communing with the data … is an
essential … requirement’’ (p. 756). More
intimate communing with the data allows a
better grasp of the problems of MAs but
cannot eliminate them. Awareness of the
limitations of blunt MAs plus sharper atten-
tion to hidden sources of variance could allow
more realistically qualified conclusions to be
drawn.
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Questions asked by an MA become more
useful when they move from the form ‘‘Is CP
effective for anxiety disorders?’’ to:
‘‘Compared with contrast-treatment condition
A, how much did CP system B improve
sufferers from anxiety-disorder C referred in
manner D and screened by method E who did
CP with F amount of human support
delivered in mode G by supporters who were
trained by method H?’’ Even these specificities
will not necessarily tell us how much improve-
ment will follow from disseminating the use of
system B into hugely varying field conditions
over a whole country. The same is true for
RCTs (and thus MAs) of any treatment, be it
a CP system, a drug, acupuncture, mind-
fulness meditation, or whatever. ‘‘Does that
treatment work?’’ becomes a more meaningful
question when refined into: ‘‘Does treatment
V improve clinical problem W if applied by
method X for Y months with surveillance
every Z months?’’ Such nuancing can counter
a cynic’s quip that ‘‘meta-analysis is to
analysis what metaphysics is to physics.’’
Unfortunately, such nuancing sharply cuts
the numbers of RCTs available for MA study
of each issue.
Conclusions
Search for a holy grail to evaluate therapy will
be in vain. Different strategies to review
therapies resemble ways of viewing the world
using a microscope or Google Earth.
Zooming in reveals detail but not the big
picture, which may be crucial. Zooming out
shows the overall shape of things but not
potentially vital details. Reviews are most
informative when they acknowledge their
distance of view and flexibly zoom in and
out, combining meta-analytic, narrative, and
other approaches. Together, these give policy-
makers a more balanced guide to the best
evidence available and enlighten researchers
and practitioners closer to the ground on the
subtleties of study design and outcomes that
can move knowledge forward in different
ways. Each strategy has its own strengths
and weaknesses.
We all want a bottom line, a simple answer
to ‘‘Does the treatment work?’’ plus a one-
page executive summary supporting the
answer. Because of uncertainties inherent in
MAs, however, a bottom line from even the
best MAs is not reliable unless placed in
context. Meta-analyses yield important evi-
dence to put in perspective along with
naturalistic reviews, open studies, and even
anecdotes to yield a realistic picture of what
CP and any other treatment can achieve.
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